Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin vs Azithromycin in Mild COVID-19
NCT04622891Completed
- Sponsor
- South Valley University
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of clarithromycin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by South Valley University. Primary endpoint: Time to fever control at 15 days. Started Apr 2020; status: completed.
02
Drugs
clarithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04622891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04622891.